Lowering Medicare Drug Prices The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Alisha Saiz2019-01-24T17:59:12+00:00January 24th, 2019|Categories: News| Share This Story FacebookTwitterLinkedInRedditGoogle+Email
